There are a variety of anxiety disorders being managed in the primary care setting. All of these are characterized by distinct differences in symptom presentation as well as treatment options. This program presents the physiology of anxiety disorders as a foundation for pharmacologic management, key features in differentiating among anxiety disorders, and pharmacologic choices for acute and chronic management.
Credits: 1.50 contact hours; 1.50 are pharmacology
Release Date: April 1, 2021
End Date: April 1, 2022
After taking part in this educational activity, participants should be better able to:
- Describe the physiologic targets of pharmacologic management of anxiety disorders.
- Compare and contrast pharmacologic options for management of anxiety disorders.
- Apply concepts presented to case studies.
Sally K. Miller, PhD, APRN, FAANP, PMHNP-BC, FNP-BC, AGACNP-BC, AGPCNP-BC
Clinical Professor, Drexel University CNHP
Nurse Practitioner, iCarePsychiatry and Sahara Family Practice
Dr. Sally Miller has been a practicing nurse practitioner for 28 years. She holds four nurse practitioner certifications including Family, Adult-Gerontology Acute Care, Adult-Gerontology Primary Care, and Psychiatric Mental Health. Dr. Miller is a clinical professor at Drexel University College of Nursing and Health Professions in Philadelphia. She maintains an active clinical practice with ICarePsychiatry. Sally has published over 30 research and clinical articles with an emphasis on issues related to adult health and illness and obesity. Dr. Miller is an active conference presenter and author in the NP community since 1996 and is a Fellow of the American Association of Nurse Practitioners.
Obtain Your Credits
To earn credits for this activity, you must complete all course components in the following order: 1) complete a three-question pre-test; 2) watch the course presentation video; 3) complete the course evaluation; 4) pass the post-test with a score of 2/3 (66.7%) or higher. You may retake the post-test until a passing score is achieved, at which point you will be able to view/print a copy of your certificate of completion. This online certificate will also be saved within your profile dashboard transcript for future access.
NPACE designates this educational activity for a maximum of 1.50 contact hours, of which 1.50 is pharmacology credit. Participants should claim only credit commensurate with the extent of their participation in the activity.
Nurse Practitioner Associates for Continuing Education (NPACE) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation (ANCC).
In addition to ANCC, NPACE is approved as a provider of continuing education in nursing by: the California Board of Registered Nursing, Provider Number CEP8720 and Florida CE Broker #50-1476.
Contributing faculty, Sally K. Miller, PhD, APRN, FAANP, PMHNP-BC, FNP-BC, AGACNP-BC, AGPCNP-BC, have disclosed no relevant financial relationships.
All planners and contributors involved in this educational activity have disclosed no relevant financial relationships.
The material presented in this continuing education program is being made available for educational purposes only and is not intended to represent the best or only methods, medications and/or guidelines appropriate for the medical situation discussed. Rather the material is intended to present an approach, view, statement, or opinion of the presenter(s), which may be helpful, or of interest to other practitioners and should not be used by clinicians without the evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. NPACE disclaims any liability, loss, injury, or damage incurred as a consequence, directly or indirectly, of the use and application of any information given in a presentation.
Disclosure of Unlabeled Use
This educational activity may mention the uses of products that are not approved by the FDA for the indication(s) being discussed. The presenter(s) are instructed to notify participants when they are discussing unapproved uses or investigational agents. The opinions related to unapproved uses of products are solely those of the presenter(s) and are not endorsed or recommended by NPACE. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
There is no commercial support for this activity.
|Access Date||Quiz Result||Score||Actions|